Summary
A large new study finds that Veterans with lung cancer who get care through the Veterans Health Administration (VA) are surviving longer than people treated at other U.S. hospitals.
Researchers looked at more than 1.4 million people diagnosed with non-small cell lung cancer, the most common type, between 2007 and 2019. They compared about 79,000 Veterans treated at the VA with about 1.38 million patients treated at community hospitals across the country.
In 2007, both groups had the same chance of being alive three years after diagnosis: 24%. By 2019, that number had climbed to 51% for Veterans treated at the VA, compared with 41% for patients treated elsewhere. The VA also did better than academic and research hospitals, which reached 46%.
The difference showed up at every stage of the disease. That stands out because the Veterans in the study were older and had more health problems than the other patients.
What might explain it? In an editorial about the study, Dr. Drew Moghanaki, a member of LCFA’s Scientific Advisory Board, and his co-authors point to how VA care is organized. National programs guide surgery, radiation and cancer medicine. Most VA medical centers partner with academic medical centers. Teams of specialists review cases together. And Veterans can get help with housing, money and transportation, the kinds of problems that can interrupt treatment.
The study did not prove why the VA did better, and it doesn’t mean every VA hospital does better than every other hospital. But it shows what’s possible when care is built around the whole person.
What this means for you: if you are a Veteran, ask your VA care team whether lung cancer screening is right for you. Finding lung cancer early gives you more treatment options.